FDA approves Mylan’s generic version of treatment for PMDD
PITTSBURGH The Food and Drug Administration has approved a generic version of Eli Lilly and Co’s Sarafem Pulvules capsules by Mylan, the Pittsburgh-based generic drug maker announced last week.
Known generically as fluoxetine, the drug is an antidepressant. Mylan said shipments of the drug in 10 mg and 20 mg strengths would begin immediately.
The branded version of the drug had sales of $19.2 million during the 12 months ending Sept. 30, according to IMS Health.
King announces acquisition of Alpharma
BRISTOL, Tenn. King Pharmaceuticals will acquire Alpharma in a deal worth $1.6 billion, King said Monday.
Alpharma had rejected a $33-per-share bid King made earlier, but accepted the most recent $37-per-share bid.
Alpharma, based in Bridgewater, N.J., has lately sought regulatory approval for painkillers designed to thwart abuse, such as Remoxy, a liquid capsule-based formulation of oxycodone.
Viagra under investigation for effect on athletes
NEW YORK The World Anti-Doping Agency is investigating whether the drug Viagra gives athletes a competitive advantage on the playing field.
The drug, known generically as sildenafil citrate and made by Pfizer, works by opening the blood vessels. According to published reports, some experts have said this could give athletes more endurance by increasing the bloodstreams ability to deliver oxygen.
If studies indicate that Viagra does give athletes an advantage, WADA will consider listing it as a performance-enhancing drug.